{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:35:36Z","timestamp":1776260136521,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T00:00:00Z","timestamp":1382486400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/2050-7771-1-28","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T17:08:01Z","timestamp":1382548081000},"source":"Crossref","is-referenced-by-count":11,"title":["Whole gene expression profile in blood reveals multiple pathways deregulation in R6\/2 mouse model"],"prefix":"10.1186","volume":"1","author":[{"given":"Daniela","family":"Diamanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Incarnato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Malusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costanza","family":"Fondelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Magnoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pollio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,23]]},"reference":[{"issue":"1","key":"57_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RAC Roos","year":"2010","unstructured":"Roos RAC: Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 2010,5(1):40.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"57_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/mp.2011.28","volume":"16","author":"D Soulet","year":"2011","unstructured":"Soulet D, Cicchetti F: The role of immunity in Huntington\u2019s disease. Mol Psychiatry 2011,16(9):889\u2013902.","journal-title":"Mol Psychiatry"},{"issue":"3\u20134","key":"57_CR3","first-page":"223","volume":"18","author":"NA Aziz","year":"2007","unstructured":"Aziz NA, Swaab DF, Pijl H, Roos RAC: Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington\u2019s disease: clinical consequences and therapeutic implications. Rev Neurosci 2007,18(3\u20134):223\u2013251.","journal-title":"Rev Neurosci"},{"issue":"3","key":"57_CR4","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E: Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 2010,90(3):905\u2013981.","journal-title":"Physiol Rev"},{"issue":"4","key":"57_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.pneurobio.2007.02.005","volume":"83","author":"AG Kazantsev","year":"2007","unstructured":"Kazantsev AG, Hersch SM: Drug targeting of dysregulated transcription in Huntington\u2019s disease. Prog Neurobiol 2007,83(4):249\u2013259.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"57_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.nbd.2011.07.001","volume":"45","author":"T Seredenina","year":"2012","unstructured":"Seredenina T, Luthi-Carter R: What have we learned from gene expression profiles in Huntington\u2019s disease? Neurobiol Dis 2012,45(1):83\u201398.","journal-title":"Neurobiol Dis"},{"issue":"42","key":"57_CR7","doi-asserted-by":"publisher","first-page":"10720","DOI":"10.1523\/JNEUROSCI.2126-08.2008","volume":"28","author":"CL Benn","year":"2008","unstructured":"Benn CL, Sun T, Sadri-Vakili G, McFarland KN, DiRocco DP, Yohrling GJ, Clark TW, Bouzou B, Cha JHJ: Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. J Neurosci 2008,28(42):10720\u201310733.","journal-title":"J Neurosci"},{"issue":"12","key":"57_CR8","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM: The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 2000,97(12):6763\u20136768.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3\u20134","key":"57_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1242\/dmm.002451","volume":"2","author":"DE Ehrnhoefer","year":"2009","unstructured":"Ehrnhoefer DE, Butland SL, Pouladi MA, Hayden MR: Mouse models of Huntington disease: variations on a theme. Dis Model Mech 2009,2(3\u20134):123\u2013129.","journal-title":"Dis Model Mech"},{"issue":"6","key":"57_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbadis.2009.04.001","volume":"1792","author":"RJ Ferrante","year":"2009","unstructured":"Ferrante RJ: Mouse models of Huntington\u2019s disease and methodological considerations for therapeutic trials. Biochim Biophys Acta 2009,1792(6):506\u2013520.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"57_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","volume":"69","author":"ZR Crook","year":"2011","unstructured":"Crook ZR, Housman D: Huntington\u2019s disease: can mice lead the way to treatment? Neuron 2011,69(3):423\u2013435.","journal-title":"Neuron"},{"issue":"1","key":"57_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-007-0306-6","volume":"115","author":"JPG Vonsattel","year":"2008","unstructured":"Vonsattel JPG: Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol 2008,115(1):55\u201369.","journal-title":"Acta Neuropathol"},{"key":"57_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies S, Bates G: Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87: 493\u2013506.","journal-title":"Cell"},{"issue":"11","key":"57_CR14","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1111\/j.1460-9568.2004.03783.x","volume":"20","author":"RR Ribchester","year":"2004","unstructured":"Ribchester RR, Thomson D, Wood NI, Hinks T, Gillingwater TH, Wishart TM, Court FA, Morton AJ: Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington\u2019s disease mutation. Eur J Neurosci 2004,20(11):3092\u20133114.","journal-title":"Eur J Neurosci"},{"issue":"4","key":"57_CR15","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1371\/journal.pgen.0030059","volume":"3","author":"AD Strand","year":"2007","unstructured":"Strand AD, Aragaki AK, Baquet ZC, Hodges A, Cunningham P, Holmans P, Jones KR, Jones L, Kooperberg C, Olson JM: Conservation of regional gene expression in mouse and human brain. PLoS Genet 2007,3(4):e59.","journal-title":"PLoS Genet"},{"issue":"2","key":"57_CR16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JHD-120042","volume":"2","author":"D Diamanti","year":"2013","unstructured":"Diamanti D, Lahiri N, Tarditi A, Magnoni L, Fondelli C, Morena E, Malusa F, Pollio G, Diodato E, Tripepi G, Tabrizi SJ, Caricasole A, Mori E: Reference genes selection for transcriptional profiling in blood of HD patients and R6\/2 mice. Journal of Huntington\u2019s Disease 2013,2(2):185\u2013200.","journal-title":"Journal of Huntington\u2019s Disease"},{"issue":"11","key":"57_CR17","doi-asserted-by":"publisher","first-page":"e8025","DOI":"10.1371\/journal.pone.0008025","volume":"4","author":"H Moffitt","year":"2009","unstructured":"Moffitt H, McPhail GD, Woodman B, Hobbs C, Bates GP: Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington\u2019s disease. PLoS One 2009,4(11):e8025.","journal-title":"PLoS One"},{"issue":"8","key":"57_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","volume":"8","author":"JMM van der Burg","year":"2009","unstructured":"van der Burg JMM, Bj\u00f6rkqvist M, Brundin P: Beyond the brain: widespread pathology in Huntington\u2019s disease. Lancet Neurol 2009,8(8):765\u2013774.","journal-title":"Lancet Neurol"},{"issue":"8","key":"57_CR19","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bj\u00f6rkqvist","year":"2008","unstructured":"Bj\u00f6rkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, Raibon E, Lee RV, Benn CL, Soulet D, Magnusson A, Woodman B, Landles C, Pouladi MA, Hayden MR, Khalili-Shirazi A, Lowdell MW, Brundin P, Bates GP, Leavitt BR, M\u00f6ller T, Tabrizi SJ: A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J Exp Med 2008,205(8):1869\u20131877.","journal-title":"J Exp Med"},{"issue":"31","key":"57_CR20","doi-asserted-by":"publisher","first-page":"11023","DOI":"10.1073\/pnas.0504921102","volume":"102","author":"F Borovecki","year":"2005","unstructured":"Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, Hersch SM, Hogarth P, Bouzou B, Jensen RV, Krainc D: Genome-wide expression profiling of human blood reveals biomarkers for Huntington\u2019s disease. Proc Natl Acad Sci U S A 2005,102(31):11023\u201311028.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"57_CR21","doi-asserted-by":"publisher","first-page":"14424","DOI":"10.1073\/pnas.0703652104","volume":"104","author":"H Runne","year":"2007","unstructured":"Runne H, Kuhn A, Wild EJ, Pratyaksha W, Kristiansen M, Isaacs JD, R\u00e9gulier E, Delorenzi M, Tabrizi SJ, Luthi-Carter R: Analysis of potential transcriptomic biomarkers for Huntington\u2019s disease in peripheral blood. Proc Natl Acad Sci U S A 2007,104(36):14424\u201314429.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"57_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcn.2008.04.012","volume":"39","author":"P Conforti","year":"2008","unstructured":"Conforti P, Ramos C, Apostol BL, Simmons DA, Nguyen HP, Riess O, Thompson LM, Zuccato C, Cattaneo E: Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington\u2019s disease: restoration by the neuroprotective compound CEP-1347. Mol Cell Neurosci 2008,39(1):1\u20137.","journal-title":"Mol Cell Neurosci"},{"issue":"7","key":"57_CR23","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1021\/pr0700753","volume":"6","author":"A Dalrymple","year":"2007","unstructured":"Dalrymple A, Wild EJ, Joubert R, Sathasivam K, Bj\u00f6rkqvist M, Peters\u00e9n A, Jackson GS, Isaacs JD, Kristiansen M, Bates GP, Leavitt BR, Keir G, Ward M, Tabrizi SJ: Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res 2007,6(7):2833\u20132840.","journal-title":"J Proteome Res"},{"issue":"Pt 4","key":"57_CR24","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/brain\/awl027","volume":"129","author":"BR Underwood","year":"2006","unstructured":"Underwood BR, Broadhurst D, Dunn WB, Ellis DI, Michell AW, Vacher C, Mosedale DE, Kell DB, Barker RA, Grainger DJ, Rubinsztein DC: Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles. Brain 2006,129(Pt 4):877\u2013886.","journal-title":"Brain"},{"issue":"12","key":"57_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.addr.2011.06.005","volume":"63","author":"MV Carroll","year":"2011","unstructured":"Carroll MV, Sim RB: Complement in health and disease. Adv Drug Deliv Rev 2011,63(12):965\u2013975.","journal-title":"Adv Drug Deliv Rev"},{"issue":"15","key":"57_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399403006252","volume":"5","author":"K Francis","year":"2003","unstructured":"Francis K, van Beek J, Canova C, Neal JW, Gasque P: Innate immunity and brain inflammation: the key role of complement. Expert Rev Mol Med 2003,5(15):1\u201319.","journal-title":"Expert Rev Mol Med"},{"key":"57_CR27","doi-asserted-by":"publisher","first-page":"563784","DOI":"10.1155\/2011\/563784","volume":"2011","author":"A Nayak","year":"2011","unstructured":"Nayak A, Ansar R, Verma SK, Bonifati DM, Kishore U: Huntington\u2019s disease: an immune perspective. Neurol Res Int 2011, 2011: 563784.","journal-title":"Neurol Res Int"},{"issue":"2","key":"57_CR28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1006\/exnr.1999.7170","volume":"159","author":"SK Singhrao","year":"1999","unstructured":"Singhrao SK, Neal JW, Morgan BP, Gasque P: Increased complement biosynthesis by microglia and complement activation on neurons in Huntington\u2019s disease. Exp Neurol 1999,159(2):362\u2013376.","journal-title":"Exp Neurol"},{"key":"57_CR29","volume-title":"PLoS Curr","author":"E Wild","year":"2011","unstructured":"Wild E, Magnusson A, Lahiri N, Krus U, Orth M, Tabrizi SJ, Bj\u00f6rkqvist M: Abnormal peripheral chemokine profile in Huntington\u2019s disease. PLoS Curr 2011., 3: RRN1231"},{"issue":"1","key":"57_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrd3011","volume":"9","author":"E Wagner","year":"2010","unstructured":"Wagner E, Frank MM: Therapeutic potential of complement modulation. Nat Rev Drug Discov 2010,9(1):43\u201356.","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"57_CR31","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/nbt1342","volume":"25","author":"D Ricklin","year":"2007","unstructured":"Ricklin D, Lambris JD: Complement-targeted therapeutics. Nat Biotechnol 2007,25(11):1265\u20131275.","journal-title":"Nat Biotechnol"},{"key":"57_CR32","doi-asserted-by":"publisher","first-page":"418765","DOI":"10.1155\/2008\/418765","volume":"2008","author":"M Kiaei","year":"2008","unstructured":"Kiaei M: Peroxisome proliferator-activated receptor-gamma in amyotrophic lateral sclerosis and Huntington\u2019s disease. PPAR Res 2008, 2008: 418765.","journal-title":"PPAR Res"},{"issue":"6","key":"57_CR33","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/hmg\/ddn428","volume":"18","author":"J Phan","year":"2009","unstructured":"Phan J, Hickey MA, Zhang P, Chesselet MF, Reue K: Adipose tissue dysfunction tracks disease progression in two Huntington\u2019s disease mouse models. Hum Mol Genet 2009,18(6):1006\u20131016.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"57_CR34","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.tins.2011.06.005","volume":"34","author":"M Valenza","year":"2011","unstructured":"Valenza M, Cattaneo E: Emerging roles for cholesterol in Huntington\u2019s disease. Trends Neurosci 2011,34(9):474\u2013486.","journal-title":"Trends Neurosci"},{"issue":"4","key":"57_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.pneurobio.2006.09.005","volume":"80","author":"M Valenza","year":"2006","unstructured":"Valenza M, Cattaneo E: Cholesterol dysfunction in neurodegenerative diseases: is Huntington\u2019s disease in the list? Prog Neurobiol 2006,80(4):165\u2013176.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"57_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jacl.2009.11.003","volume":"4","author":"RC Block","year":"2010","unstructured":"Block RC, Dorsey ER, Beck CA, Brenna JT, Shoulson I: Altered cholesterol and fatty acid metabolism in Huntington disease. J Clin Lipidol 2010,4(1):17\u201323.","journal-title":"J Clin Lipidol"},{"issue":"7","key":"57_CR37","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1089\/ars.2010.3359","volume":"14","author":"G Z\u00fcndorf","year":"2011","unstructured":"Z\u00fcndorf G, Reiser G: Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxid Redox Signal 2011,14(7):1275\u20131288.","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"57_CR38","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.bbrc.2004.08.035","volume":"322","author":"I Bezprozvanny","year":"2004","unstructured":"Bezprozvanny I, Hayden MR: Deranged neuronal calcium signaling and Huntington disease. Biochem Biophys Res Commun 2004,322(4):1310\u20131317.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"57_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10863-010-9286-7","volume":"42","author":"YN Jin","year":"2010","unstructured":"Jin YN, Johnson GVW: The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease. Journal of bioenergetics and biomembranes 2010,42(3):199\u2013205.","journal-title":"Journal of bioenergetics and biomembranes"},{"issue":"9","key":"57_CR40","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1074\/jbc.M704704200","volume":"283","author":"D Lim","year":"2008","unstructured":"Lim D, Fedrizzi L, Tartari M, Zuccato C, Cattaneo E, Brini M, Carafoli E: Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease. J Biol Chem 2008,283(9):5780\u20135789.","journal-title":"J Biol Chem"},{"issue":"1","key":"57_CR41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","volume":"1802","author":"M Damiano","year":"2010","unstructured":"Damiano M, Galvan L, D\u00e9glon N, Brouillet E: Mitochondria in Huntington\u2019s disease. Biochim Biophys Acta 2010,1802(1):52\u201361.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"57_CR42","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1006\/jmcc.2001.1378","volume":"33","author":"EJ Lesnefsky","year":"2001","unstructured":"Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL: Mitochondrial dysfunction in cardiac disease: ischemia\u2013reperfusion, aging, and heart failure. Journal of molecular and cellular cardiology 2001,33(6):1065\u20131089.","journal-title":"Journal of molecular and cellular cardiology"},{"issue":"12","key":"57_CR43","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/jmg.29.12.911","volume":"29","author":"SA Sorensen","year":"1992","unstructured":"Sorensen SA, Fenger K: Causes of death in patients with Huntington\u2019s disease and in unaffected first degree relatives. Journal of medical genetics 1992,29(12):911\u2013914.","journal-title":"Journal of medical genetics"},{"issue":"1","key":"57_CR44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JHD-2012-120004","volume":"1","author":"NI Wood","year":"2012","unstructured":"Wood NI, Sawiak SJ, Buonincontri G, Niu Y, Kane AD, Carpenter AT, Giussani DA, Morton AJ: Direct evidence of progressive cardiac dysfunction in a transgenic mouse model of Huntington\u2019s disease. Journal of Huntington\u2019s Disease 2012,1(1):57\u201364.","journal-title":"Journal of Huntington\u2019s Disease"},{"issue":"2","key":"57_CR45","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.nbd.2006.09.016","volume":"25","author":"MJ Mihm","year":"2007","unstructured":"Mihm MJ, Amann DM, Schanbacher BL, Altschuld RA, Bauer JA, Hoyt KR: Cardiac dysfunction in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol Dis 2007,25(2):297\u2013308.","journal-title":"Neurobiol Dis"},{"issue":"3\u20134","key":"57_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11568-008-9017-x","volume":"1","author":"H Aziz","year":"2007","unstructured":"Aziz H, Zaas A, Ginsburg GS: Peripheral blood gene expression profiling for cardiovascular disease assessment. Genomic Medicine 2007,1(3\u20134):105\u2013112.","journal-title":"Genomic Medicine"},{"issue":"10","key":"57_CR47","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.molmed.2007.08.003","volume":"13","author":"S Mohr","year":"2007","unstructured":"Mohr S, Liew CC: The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol Med 2007,13(10):422\u2013432.","journal-title":"Trends Mol Med"},{"key":"57_CR48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2105-4-26","volume":"4","author":"X Peng","year":"2003","unstructured":"Peng X, Wood CL, Blalock EM, Chen KC, Landfield PW, Stromberg AJ: Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinforma 2003, 4: 26.","journal-title":"BMC Bioinforma"},{"issue":"1","key":"57_CR49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/JHD-2012-120021","volume":"1","author":"PB Larkin","year":"2012","unstructured":"Larkin PB, Muchowski PJ: Genetic deficiency of complement component 3 does not alter disease progression in a mouse model of Huntington\u2019s disease. J Huntingtons Dis 2012,1(1):107\u2013118.","journal-title":"J Huntingtons Dis"},{"issue":"1","key":"57_CR50","doi-asserted-by":"publisher","first-page":"E49","DOI":"10.1152\/ajpendo.00630.2010","volume":"301","author":"P She","year":"2011","unstructured":"She P, Zhang Z, Marchionini D, Diaz WC, Jetton TJ, Kimball SR, Vary TC, Lang CH, Lynch CJ: Molecular characterization of skeletal muscle atrophy in the R6\/2 mouse model of Huntington\u2019s disease. Am J Physiol Endocrinol Metab 2011,301(1):E49-E61.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"17","key":"57_CR51","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","volume":"11","author":"R Luthi-Carter","year":"2002","unstructured":"Luthi-Carter R, Hanson SA, Strand AD, Bergstrom DA, Chun W, Peters NL, Woods AM, Chan EY, Kooperberg C, Krainc D, Young AB, Tapscott SJ, Olson JM: Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum Mol Genet 2002,11(17):1911\u20131926.","journal-title":"Hum Mol Genet"},{"issue":"13","key":"57_CR52","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1093\/hmg\/ddi192","volume":"14","author":"AD Strand","year":"2005","unstructured":"Strand AD, Aragaki AK, Shaw D, Bird T, Holton J, Turner C, Tapscott SJ, Tabrizi SJ, Schapira AH, Kooperberg C, Olson JM: Gene expression in Huntington\u2019s disease skeletal muscle: a potential biomarker. Hum Mol Genet 2005,14(13):1863\u20131876.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"57_CR53","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.burns.2009.06.211","volume":"36","author":"3J Greco","year":"2010","unstructured":"Greco 3J, Pollins AC, Boone BE, Levy SE, Nanney LB: A microarray analysis of temporal gene expression profiles in thermally injured human skin. Burns 2010,36(2):192\u2013204.","journal-title":"Burns"},{"issue":"5","key":"57_CR54","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1074\/mcp.M200016-MCP200","volume":"1","author":"C Zabel","year":"2002","unstructured":"Zabel C, Chamrad DC, Priller J, Woodman B, Meyer HE, Bates GP, Klose J: Alterations in the mouse and human proteome caused by Huntington\u2019s disease. Mol Cell Proteomics 2002,1(5):366\u2013375.","journal-title":"Mol Cell Proteomics"},{"issue":"6","key":"57_CR55","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, Hollingsworth ZR, Collin F, Synek B, Holmans PA, Young AB, Wexler NS, Delorenzi M, Kooperberg C, Augood SJ, Faull RLM, Olson JM, Jones L, Luthi-Carter R: Regional and cellular gene expression changes in human Huntington\u2019s disease brain. Hum Mol Genet 2006,15(6):965\u2013977.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"57_CR56","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JYH, Zhang J: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004,5(10):R80.","journal-title":"Genome Biol"},{"issue":"4","key":"57_CR57","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1093\/nar\/gng015","volume":"31","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of affymetrix genechip probe level data. Nucleic Acids Res 2003,31(4):e15.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"57_CR58","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","volume":"19","author":"BM Bolstad","year":"2003","unstructured":"Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003,19(2):185\u2013193.","journal-title":"Bioinformatics"},{"key":"57_CR59","volume-title":"Stat Appl Genet Mol Biol","author":"GK Smyth","year":"2004","unstructured":"Smyth GK: Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004., 3: article 3"},{"issue":"43","key":"57_CR60","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005,102(43):15545\u201315550.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"57_CR61","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","volume":"29","author":"W Luo","year":"2013","unstructured":"Luo W, Brouwer C: Pathview: an R\/Bioconductor package for pathway-based data integration and visualization. Bioinformatics 2013,29(14):1830\u20131831.","journal-title":"Bioinformatics"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-7771-1-28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2050-7771-1-28\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-7771-1-28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T16:39:35Z","timestamp":1596731975000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/2050-7771-1-28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,23]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1186\/2050-7771-1-28","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,23]]},"article-number":"28"}}